VARIATIONAL AI
Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline.
VARIATIONAL AI
Industry:
Artificial Intelligence (AI) Biotechnology Generative AI Machine Learning
Founded:
2019-09-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.variational.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.66 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network LetsEncrypt
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Elucidata
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Deepbrain AI
Deepbrain AI provides a range of AI powered customer service products.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Amarjit Gill
Amarjit Gill investment in Seed Round - Variational AI
Lip-Bu Tan
Lip-Bu Tan investment in Seed Round - Variational AI
Flying Fish Partners
Flying Fish Partners investment in Seed Round - Variational AI
Alliance of Angels
Alliance of Angels investment in Seed Round - Variational AI
A&E Investments
A&E Investments investment in Seed Round - Variational AI
UBC Seed Fund
UBC Seed Fund investment in Pre Seed Round - Variational AI
Official Site Inspections
http://www.variational.ai Semrush global rank: 7.09 M Semrush visits lastest month: 890
- Host name: 192.117.136.34.bc.googleusercontent.com
- IP address: 34.136.117.192
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Variational AI"
Variational AI - We discover novel drug-like small molecules
We are a team of AI/machine learning and business specialists using advanced generative AI for drug discovery. We collaborate closely with biopharmaceutical partners to develop new …See details»
Variational AI - Crunchbase Company Profile & Funding
Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase …See details»
Press - Variational AI
Sep 14, 2024 · Generative AI in drug discovery is showing promise by optimizing molecule searches beyond traditional methods. Variational AI’s Enki algorithm created 100 AI-generated …See details»
Variational AI announces generative AI project with …
Jan 25, 2024 · Variational AI is redefining the unit economics of drug discovery and development through the power of generative AI. Variational AI’s Enkiâ„¢ Platform is a foundation model for small molecule drug discovery to accelerate …See details»
Variational AI - LinkedIn
Variational AI has developed Enki, the biopharma industry's first commercially-available foundation model for small molecules. Enki is based on a novel generative AI framework invented by...See details»
Variational AI - Life Sciences British Columbia
Variational AI has developed an AI-based platform to rapidly generate novel multi-target kinase inhibitors focused on solid tumor indications.See details»
Industry viewpoint: Variational AI - BioTalent Canada
Since September 2019, Variational AI’s team of experienced AI/machine learning and business specialists has been collaborating with biopharmaceutical partners to apply generative AI to …See details»
Our Approach - Variational AI
Our answer is to leverage a powerful new form of machine learning known as generative AI to free us from reliance on screening and libraries, both experimental and virtual, to generate de novo molecules with all the optimized …See details»
B.C. AI venture Variational AI partners with Merck
Jan 25, 2024 · Multinational drug developer Merck is partnering with a Vancouver-based artificial intelligence (AI) company that has a platform that enables drug makers to quickly create recipes for specific...See details»
Variational AI Announces Generative AI Project With Merck
Variational AI, developer of the Enkiâ„¢ generative artificial intelligence (AI) platform for drug discovery, announced a project with Merck, known as MSD outside of the United States and …See details»
Variational AI - Funding, Financials, Valuation & Investors
Variational AI is funded by 6 investors. Amarjit Gill and Lip-Bu Tan are the most recent investors. in funding over 2 rounds. Their latest funding was raised on Nov 17, 2021 from a Seed round. …See details»
Vancouver-based Variational AI Announces Generative AI Project …
Jan 29, 2024 · Variational AI is redefining the unit economics of drug discovery and development through the power of generative AI. Variational AI's Enkiâ„¢ Platform is a foundation model for …See details»
Variational AI Announces Generative AI Project with Merck
Jan 25, 2024 · Variational AI is redefining the unit economics of drug discovery and development through the power of generative AI. Variational AI’s Enkiâ„¢ Platform is a foundation model for …See details»
Variational AI Secures $US3.5 Million in Seed Funding to Apply …
Nov 17, 2021 · Variational AI’s Enki algorithm learns from a training set of molecules screened against drug targets from both experimental and computational sources and then generates …See details»
Variational AI - Products, Competitors, Financials, Employees ...
Variational AI is a healthcare company. The company uses artificial intelligence to develop new small-molecule drugs. It was founded in 2019 and is based in Vancouver, Canada. The ESP …See details»
Variational AI Announces Generative AI Project With Merck
Jan 25, 2024 · Variational AI is redefining the unit economics of drug discovery and development through the power of generative AI. Variational AI’s Enkiâ„¢ Platform is a foundation model for …See details»
Handol Kim of Variational AI On The Future Of Artificial ... - Medium
Jul 12, 2022 · Handol is Co-Founder & CEO of Variational AI, a Vancouver-based AI for drug discovery start-up developing novel therapeutics in oncology and beyond.See details»
Variational AI Adds Jennifer Hamilton as Advisor
Oct 26, 2022 · VANCOUVER, BC — Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and …See details»
Variational AI Adds Jennifer Hamilton as Advisor
Vancouver, BC – October 26, 2022 – Variational AI, developer of generative AI-based drug discovery platform for novel kinase inhibitors, today announced that it has added industry and …See details»
Variational AI Partners with the University of British Columbia and ...
Dec 15, 2021 · Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to …See details»